Cargando…
Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer
New breast cancer biomarkers have been sought for better tumor characterization and treatment. Among these putative markers, there is Biglycan (BGN). BGN is a class I small leucine-rich proteoglycan family of proteins characterized by a protein core with leucine-rich repeats. The objective of this s...
Autores principales: | Thiesen, Ana Paula, Mielczarski, Bruna, Savaris, Ricardo Francalacci |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042358/ https://www.ncbi.nlm.nih.gov/pubmed/36972253 http://dx.doi.org/10.1371/journal.pone.0282176 |
Ejemplares similares
-
Breast cancer dataset with biomarker Biglycan
por: Silva Neto, Pedro Clarindo da, et al.
Publicado: (2023) -
Expression and the Prognostic Value of Biglycan in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2022) -
Biglycan expression and its function in human ligamentum flavum
por: Salimi, Hamidullah, et al.
Publicado: (2021) -
IGF-1 Upregulates Biglycan and Decorin by Increasing Translation and Reducing ADAMTS5 Expression
por: Lee, Hanon, et al.
Publicado: (2021) -
Decorin knockdown is beneficial for aged tendons in the presence of biglycan expression
por: Beach, Zakary M., et al.
Publicado: (2022)